← Back to All US Stocks

CCM Stock Analysis - Concord Medical Services Holdings Ltd AI Rating

CCM NYSE Services-Offices & Clinics of Doctors of Medicine E9 CIK: 0001472072
Recently Updated • Analysis: Mar 22, 2026 • SEC Data: 2026-03-22
AI Rating
HOLD
5% Confidence

📊 CCM Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: HOLD with 5% confidence

Investment Thesis

Unable to conduct meaningful fundamental analysis due to unavailable financial data across all key metrics. The company appears to have significant data reporting gaps that prevent assessment of profitability, financial health, cash flow generation, or operational performance.

CCM Strengths

  • -No strengths identified

CCM Risks

  • ! Complete absence of income statement data prevents profitability assessment
  • ! No balance sheet data available to evaluate financial position and solvency
  • ! Missing cash flow statements prevent evaluation of cash generation and capital allocation
  • ! No insider activity in last 90 days suggests potential lack of confidence or limited trading window
  • ! Extremely low data quality score indicates potential company delinquency in SEC reporting or data aggregation failure

Key Metrics to Watch

CCM Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

CCM Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

CCM vs Default Sector

How Concord Medical Services Holdings Ltd compares to Default sector averages

Net Margin
CCM 0.0%
vs
Sector Avg 12.0%
CCM Sector
ROE
CCM 0.0%
vs
Sector Avg 15.0%
CCM Sector
Current Ratio
CCM 0.0x
vs
Sector Avg 1.8x
CCM Sector
Debt/Equity
CCM 0.0x
vs
Sector Avg 0.7x
CCM Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CCM Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

CCM Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

CCM SEC Filings

Access official SEC EDGAR filings for Concord Medical Services Holdings Ltd (CIK: 0001472072)

📋 Recent SEC Filings

Date Form Document Action
Mar 19, 2019 SC 13D tv516495_sc13d.htm View →
Nov 13, 2017 SC 13D tv478829_sc13d.htm View →
Dec 13, 2013 SC 13G d631464dsc13g.htm View →
Aug 15, 2013 SC 13D d585529dsc13d.htm View →
Feb 14, 2011 SC 13G h04840sc13g.htm View →

Frequently Asked Questions about CCM

What is the AI rating for CCM?

Concord Medical Services Holdings Ltd (CCM) has an AI rating of HOLD with 5% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CCM's key strengths?

.

What are the risks of investing in CCM?

Complete absence of income statement data prevents profitability assessment. No balance sheet data available to evaluate financial position and solvency.

What is CCM's revenue and growth?

Concord Medical Services Holdings Ltd reported revenue of N/A.

Does CCM pay dividends?

Concord Medical Services Holdings Ltd does not currently pay dividends.

Where can I find CCM SEC filings?

Official SEC filings for Concord Medical Services Holdings Ltd (CIK: 0001472072) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CCM's EPS?

Concord Medical Services Holdings Ltd has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 22, 2026 | Data as of: 2026-03-22 | Powered by Claude AI